Silibinin: a potential old drug for cancer therapyXingxing Zhu, Qiang He, Yi Wu et al.|Expert Review of Clinical Pharmacology|2016Cited by 64
MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic CancerXinxue Zhang, Qiang He|Journal of Oncology|2022Cited by 7